Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Clinical trial NCT07282912 · RECRUITING

Trial details

NCT number: NCT07282912
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Foregut Adenocarcinoma Esophageal Adenocarcinoma Gastroesophageal Adenocarcinoma Gastric Adenocarcinoma Pancreas Adenocarcinoma Duodenal Adenocarcinoma Ampullary Adenocarcinoma Gallbladder Adenocarcinoma Intra - and Extrahepatic Cholangiocarcinoma

Start date: 2026-06-02
Primary completion: 2028-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.